Newsroom | 9543 results

Sorted by: Latest

Mental Health
-

SFI Health™ Reports Promising Results From a Preliminary Study Evaluating the Impact of Long-Chain Polyunsaturated Fatty Acids on Reading and Writing Skills in Children

LUGANO, Switzerland--(BUSINESS WIRE)--SFI Health reports publication of the results from a study about the impact of Long-Chain Polyunsaturated Fatty Acids on literacy skills in children....
-

Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience

MANHASSET, N.Y.--(BUSINESS WIRE)--Recent reports show that one in seven first responders have probable post-traumatic stress disorder (PTSD) in response to routine duties with prevalence increasing after responding to a crisis. To improve our understanding and the well-being of these essential heroes, researchers at Northwell Health’s Feinstein Institutes for Medical Research, Stony Brook University and Texas A&M University received a $3.37-million grant from the National Institute of Menta...
-

Vistagen Reports Findings on PH80’s Brain and Autonomic Effects in Women with Menopausal Hot Flashes at The Menopause Society 2025 Annual Meeting

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, presented exploratory data at The Menopause Society 2025 Annual Meeting in Orlando, Florida. These findings demonstrate PH80’s potential as a rapidly-acting pherine product candidate for treating vasomotor symptoms (hot flashes) du...
-

Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that it has received a Notice of Allowance (NOA) from the United States Patent and Trademark Office (USPTO) for a patent application pertaining to its EVM401 Series of molecules being developed as potential treatments for mental health disorders....
-

With Two in Five Employees Undergoing Fertility Treatment Leaving Their Jobs or Considering Quitting, Are Companies Doing Enough?

SAINT-PREX, Switzerland--(BUSINESS WIRE)--An international survey, spanning Australia, France, Japan, Poland and the UK, has found that many employees experiencing fertility challenges lack support in the workplace, with almost two in five (39%) leaving or considering leaving their roles while undergoing treatment.1 ‘The Impact of Fertility Challenges at Work: International Insights’ survey by Ferring Pharmaceuticals, Fertility Matters at Work and This Can Happen shows that, despite growing awa...
-

Alkermes to Participate in Two Upcoming Investor Conferences

DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) announced today that management will participate in two upcoming investor conferences. 8th Annual Evercore Healthcare Conference Date/Time: Wednesday, Dec. 3, 2025 at 2:10 p.m. ET (7:10 p.m. GMT) Piper Sandler 37th Annual Healthcare Conference Date/Time: Thursday, Dec. 4, 2025 at 12:00 p.m. ET (5:00 p.m. GMT) The live webcasts may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days. About Alkermes plc Alke...
-

LivaNova to Present at Piper Sandler Healthcare Conference in December

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Alex Shvartsburg, Chief Financial Officer, will present a general business update during a fireside chat at the Piper Sandler 37th Annual Healthcare Conference in New York City. The presentation will take place on Tues., Dec. 2, at 1:30 p.m. Eastern Standard Time. The discussion will be available to all interested parties who register to attend the webcast, which is accessible...
-

Contineum Therapeutics to Attend the 8th Annual Evercore Healthcare Conference

SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced that management is scheduled to participate in a fireside chat at the 8th Annual Evercore Healthcare Conference in Miami on Wednesday, December 3, 2025 at 1:20 p.m. ET. An audio webcast of the fireside chat can be acc...
-

Anthem Blue Cross and Blue Shield Foundation and The Open Table, Inc. Launch Year 2 of the “Strengthening Shenandoah” Initiative to Expand Substance Use Disorder Services for Children and Families

WOODSTOCK, Va.--(BUSINESS WIRE)--As part of its ongoing commitment to programs supporting mental health and well-being, the Anthem Blue Cross and Blue Shield Foundation is partnering with The Open Table, Inc. to strengthen Shenandoah County’s response to substance use disorder (SUD) among children and adolescents. Through a $750,000 grant, The Open Table has launched Strengthening Shenandoah, a collaborative initiative uniting the Shenandoah Juvenile and Domestic Relations Court, Shenandoah Cou...
-

How Elevance Health is Evolving the Healthcare Consumer Experience Through Improved Personalization and Higher Touch Service

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health is making healthcare more intuitive and personalized by using technology to simplify access and build trust among health plan members....